Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.18 USD | -12.45% | -8.21% | -82.48% |
May. 14 | Transcript : Vivos Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Vivos Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-82.48% | 6.5M | |
+73.63% | 12.42B | |
-18.62% | 7.94B | |
-0.90% | 6.17B | |
+14.66% | 5.5B | |
+39.93% | 5.01B | |
-16.05% | 4.88B | |
-16.42% | 4.2B | |
-27.62% | 2.73B | |
+40.99% | 2.27B |
- Stock Market
- Equities
- VVOS Stock
- News Vivos Therapeutics, Inc.
- Vivos Therapeutics : Roth Capital Starts Vivos Therapeutics at Buy With $12 Price Target